Identification of synaptosomal proteins binding to monomeric and oligomeric α-synuclein

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Betzer, Cristine ^a   Movius, A James ^b   Shi, Min ^b   Gai, Wei Ping ^c   Zhang, Jing ^b   Jensen, Poul Henning ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b FLINDERS UNIVERSITY   (Australia)

^c University of the Washington School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; ALPHA SYNUCLEIN; BINDING PROTEIN; DETERGENT; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE DECARBOXYLASE; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; MONOMER; MYELIN; OLIGOMER; RECOMBINANT PROTEIN; SYNAPSIN I; SYNAPTOBREVIN 2; SYNAPTOSOMAL PROTEIN; UNCLASSIFIED DRUG; NERVE PROTEIN; PROTEIN BINDING;

ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; CONTROLLED STUDY; FRACTIONATION; HUMAN; HUMAN TISSUE; IMMUNOPRECIPITATION; LIQUID CHROMATOGRAPHY; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEOMICS; QUANTITATIVE ANALYSIS; SOLUBILIZATION; SWINE; TANDEM MASS SPECTROMETRY; ANIMAL; BRAIN; CHEMISTRY; METABOLISM; PIG; PROCEDURES; PROTEIN MULTIMERIZATION; SYNAPTOSOME;

SUS;

ALPHA-SYNUCLEIN; ANIMALS; BRAIN; HUMANS; NERVE TISSUE PROTEINS; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEOMICS; SWINE; SYNAPTOSOMES;

EID: 84922668668     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0116473     Document Type: Article

References (73)

1. Spillantini MG (1999) Parkinson's disease, dementia with Lewy bodies and multiple system atrophy are alpha-synucleinopathies. Parkinsonism Relat Disord 5: 157-162. doi: 10.1016/S1353-8020(99)00031- 0 PMID: 18591134
2. Goedert M, Spillantini MG (1998) Lewy body diseases and multiple system atrophy as alphasynucleinopathies. Mol Psychiatry 3: 462-465. doi: 10.1038/sj.mp.4000458 PMID: 9857966
3. Conway KA, Harper JD, Lansbury PT (1998) Accelerated in vitro fibril formation by a mutant alphasynuclein linked to early-onset Parkinson disease. Nat Med 4: 1318-1320. doi: 10.1038/3311 PMID: 9809558
4. Giasson BI, Uryu K, Trojanowski JQ, Lee VM (1999) Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro. J Biol Chem 274: 7619-7622. doi: 10.1074/jbc.274.12.7619 PMID: 10075647
5. Hashimoto M, Hsu LJ, Sisk A, Xia Y, Takeda A, et al. (1998) Human recombinant NACP/alpha-synuclein is aggregated and fibrillated in vitro: relevance for Lewy body disease. Brain Res 799: 301-306. doi: 10.1016/S0006-8993(98)00514-9 PMID: 9675319
6. Jakes R, Spillantini MG, Goedert M (1994) Identification of two distinct synucleins from human brain. FEBS Lett 345: 27-32. doi: 10.1016/0014-5793(94)00395-5 PMID: 8194594
7. Burre J, Sharma M, Tsetsenis T, Buchman V, Etherton MR, et al. (2010) Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science 329: 1663-1667. doi: 10.1126/science. 1195227 PMID: 20798282
8. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, et al. (1997) Mutation in the alphasynuclein gene identified in families with Parkinson's disease. Science 276: 2045-2047. doi: 10.1126/science.276.5321.2045 PMID: 9197268
9. Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, et al. (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 18: 106-108. doi: 10.1038/ng0298-106 PMID: 9462735
10. Zarranz JJ, Alegre J, Gomez-Esteban JC, Lezcano E, Ros R, et al. (2004) The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55: 164-173. doi: 10.1002/ana.10795 PMID: 14755719
11. Appel-Cresswell S, Vilarino-Guell C, Encarnacion M, Sherman H, Yu I, et al. (2013) Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease. Mov Disord 28: 811-813. doi: 10.1002/mds.25421 PMID: 23457019
12. Lesage S, Anheim M, Letournel F, Bousset L, Honore A, et al. (2013) G51D alpha-synuclein mutation causes a novel parkinsonian-pyramidal syndrome. Ann Neurol 73: 459-471. doi: 10.1002/ana.23894 PMID: 23526723
13. Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, et al. (2003) alpha-Synuclein locus triplication causes Parkinson's disease. Science 302: 841. doi: 10.1126/science.1090278 PMID: 14593171
14. Chartier-Harlin MC, Kachergus J, Roumier C, Mouroux V, Douay X, et al. (2004) Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 364: 1167-1169. doi: 10.1016/S0140- 6736(04)17103-1 PMID: 15451224
15. Simon-Sanchez J, Schulte C, Bras JM, Sharma M, Gibbs JR, et al. (2009) Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet 41: 1308-1312. doi: 10.1038/ng. 487 PMID: 19915575
16. Pankratz N, Wilk JB, Latourelle JC, DeStefano AL, Halter C, et al. (2009) Genomewide association study for susceptibility genes contributing to familial Parkinson disease. Hum Genet 124: 593-605. doi: 10.1007/s00439-008-0582-9 PMID: 18985386
17. Lill CM, Roehr JT, McQueen MB, Kavvoura FK, Bagade S, et al. (2012) Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database. PLoS Genet 8: e1002548. doi: 10.1371/journal.pgen.1002548 PMID: 22438815
18. Hoffman-Zacharska D, Koziorowski D, Ross OA, Milewski M, Poznanski J, et al. (2013) Novel A18T and pA29S substitutions in alpha-synuclein may be associated with sporadic Parkinson's disease. Parkinsonism Relat Disord. doi: 10.1016/j.parkreldis.2013.07.011 PMID: 23916651
19. Kalia LV, Kalia SK, McLean PJ, Lozano AM, Lang AE (2013) alpha-Synuclein oligomers and clinical implications for Parkinson disease. Ann Neurol 73: 155-169. doi: 10.1002/ana.23746 PMID: 23225525
20. Olanow CW, Brundin P (2013) Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder? Mov Disord 28: 31-40. doi: 10.1002/mds.25373 PMID: 23390095
21. Paleologou KE, Kragh CL, Mann DM, Salem SA, Al-Shami R, et al. (2009) Detection of elevated levels of soluble alpha-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies. Brain 132: 1093-1101. doi: 10.1093/brain/awn349 PMID: 19155272
22. Colla E, Jensen PH, Pletnikova O, Troncoso JC, Glabe C, et al. (2012) Accumulation of toxic alphasynuclein oligomer within endoplasmic reticulum occurs in alpha-synucleinopathy in vivo. J Neurosci 32: 3301-3305. doi: 10.1523/JNEUROSCI.5368-11.2012 PMID: 22399752
23. Rockenstein E, Nuber S, Overk CR, Ubhi K, Mante M, et al. (2014) Accumulation of oligomer-prone alpha-synuclein exacerbates synaptic and neuronal degeneration in vivo. Brain 137: 1496-1513. doi: 10.1093/brain/awu057 PMID: 24662516
24. Hansson O, Hall S, Ohrfelt A, Zetterberg H, Blennow K, et al. (2014) Levels of cerebrospinal fluid alphasynuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease. Alzheimers Res Ther 6: 25. doi: 10.1186/alzrt255 PMID: 24987465
25. Kramer ML, Schulz-Schaeffer WJ (2007) Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. J Neurosci 27: 1405-1410. doi: 10.1523/JNEUROSCI.4564-06.2007 PMID: 17287515
26. Luk KC, Kehm V, Carroll J, Zhang B, O'Brien P, et al. (2012) Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338: 949-953. doi: 10. 1126/science.1227157 PMID: 23161999
27. Masuda-Suzukake M, Nonaka T, Hosokawa M, Oikawa T, Arai T, et al. (2013) Prion-like spreading of pathological alpha-synuclein in brain. Brain 136: 1128-1138. doi: 10.1093/brain/awt037 PMID: 23466394
28. Anderson NL, Anderson NG (1998) Proteome and proteomics: new technologies, new concepts, and new words. Electrophoresis 19: 1853-1861. doi: 10.1002/elps.1150191103 PMID: 9740045
29. Blackstock WP, Weir MP (1999) Proteomics: quantitative and physical mapping of cellular proteins. Trends Biotechnol 17: 121-127. doi: 10.1016/S0167-7799(98)01245-1 PMID: 10189717
30. Anderson JP, Walker DE, Goldstein JM, de Laat R, Banducci K, et al. (2006) Phosphorylation of Ser- 129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease. J Biol Chem 281: 29739-29752. doi: 10.1074/jbc.M600933200 PMID: 16847063
31. Ohrfelt A, Zetterberg H, Andersson K, Persson R, Secic D, et al. (2011) Identification of novel alphasynuclein isoforms in human brain tissue by using an online nanoLC-ESI-FTICR-MS method. Neurochem Res 36: 2029-2042. doi: 10.1007/s11064-011-0527-x PMID: 21674238
32. Hong Z, Shi M, Chung KA, Quinn JF, Peskind ER, et al. (2010) DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease. Brain 133: 713-726. doi: 10.1093/brain/awq008 PMID: 20157014
33. Zhou Y, Gu G, Goodlett DR, Zhang T, Pan C, et al. (2004) Analysis of alpha-synuclein-associated proteins by quantitative proteomics. J Biol Chem 279: 39155-39164. doi: 10.1074/jbc.M405456200 PMID: 15234983
34. Jin J, Li GJ, Davis J, Zhu D, Wang Y, et al. (2007) Identification of novel proteins associated with both alpha-synuclein and DJ-1. Mol Cell Proteomics 6: 845-859. doi: 10.1074/mcp.M600182-MCP200 PMID: 16854843
35. McFarland MA, Ellis CE, Markey SP, Nussbaum RL (2008) Proteomics analysis identifies phosphorylation- dependent alpha-synuclein protein interactions. Mol Cell Proteomics 7: 2123-2137. doi: 10.1074/mcp.M800116-MCP200 PMID: 18614564
36. Lindersson E, Beedholm R, Hojrup P, Moos T, Gai W, et al. (2004) Proteasomal inhibition by alphasynuclein filaments and oligomers. J Biol Chem 279: 12924-12934. doi: 10.1074/jbc.M306390200 PMID: 14711827
37. Huttner WB, Schiebler W, Greengard P, De Camilli P (1983) Synapsin I (protein I), a nerve terminalspecific phosphoprotein. III. Its association with synaptic vesicles studied in a highly purified synaptic vesicle preparation. J Cell Biol 96: 1374-1388.
38. Michalski A, Cox J, Mann M (2011) More than 100, 000 detectable peptide species elute in single shotgun proteomics runs but the majority is inaccessible to data-dependent LC-MS/MS. J Proteome Res 10: 1785-1793. doi: 10.1021/pr101060v PMID: 21309581
39. Schilling B, Rardin MJ, MacLean BX, Zawadzka AM, Frewen BE, et al. (2012) Platform-independent and label-free quantitation of proteomic data using MS1 extracted ion chromatograms in skyline: application to protein acetylation and phosphorylation. Mol Cell Proteomics 11: 202-214. doi: 10.1074/mcp. M112.017707 PMID: 22454539
40. Huang C, Ren G, Zhou H, Wang CC (2005) A new method for purification of recombinant human alphasynuclein in Escherichia coli. Protein Expr Purif 42: 173-177. doi: 10.1016/j.pep.2005.02.014 PMID: 15939304
41. Lashuel HA, Petre BM, Wall J, Simon M, Nowak RJ, et al. (2002) Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils. J Mol Biol 322: 1089-1102. doi: 10.1016/S0022-2836(02)00735-0 PMID: 12367530
42. Kubo SI, Kitami T, Noda S, Shimura H, Uchiyama Y, et al. (2001) Parkin is associated with cellular vesicles. J Neurochem 78: 42-54. doi: 10.1046/j.1471-4159.2001.00364.x PMID: 11432972
43. Lin X, Cook TJ, Zabetian CP, Leverenz JB, Peskind ER, et al. (2012) DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease. Sci Rep 2: 954. doi: 10.1038/srep00954 PMID: 23233873
44. Vizcaino JA, Deutsch EW, Wang R, Csordas A, Reisinger F, et al. (2014) ProteomeXchange provides globally coordinated proteomics data submission and dissemination. Nat Biotechnol 32: 223-226. doi: 10.1038/nbt.2839 PMID: 24727771
45. Kragh CL, Lund LB, Febbraro F, Hansen HD, Gai WP, et al. (2009) {alpha}-Synuclein Aggregation and Ser-129 Phosphorylation-dependent Cell Death in Oligodendroglial Cells. J Biol Chem 284: 10211-10222. doi: 10.1074/jbc.M809671200 PMID: 19203998
46. Lee BR, Kamitani T (2011) Improved immunodetection of endogenous alpha-synuclein. PLoS One 6: e23939. doi: 10.1371/journal.pone.0023939 PMID: 21886844
47. Otzen DE, Lundvig DM, Wimmer R, Nielsen LH, Pedersen JR, et al. (2005) p25alpha is flexible but natively folded and binds tubulin with oligomeric stoichiometry. Protein Sci 14: 1396-1409. doi: 10.1110/ps.041285605 PMID: 15883183
48. Lindersson E, Lundvig D, Petersen C, Madsen P, Nyengaard JR, et al. (2005) p25alpha Stimulates alpha-synuclein aggregation and is co-localized with aggregated alpha-synuclein in alphasynucleinopathies. J Biol Chem 280: 5703-5715. doi: 10.1074/jbc.M410409200 PMID: 15590652
49. Sharrad DF, Gai WP, Brookes SJ (2013) Selective coexpression of synaptic proteins, alpha-synuclein, cysteine string protein-alpha, synaptophysin, synaptotagmin-1, and synaptobrevin-2 in vesicular acetylcholine transporter-immunoreactive axons in the guinea pig ileum. J Comp Neurol 521: 2523-2537. doi: 10.1002/cne.23296 PMID: 23296877
50. Conway KA, Rochet JC, Bieganski RM, Lansbury PT Jr (2001) Kinetic stabilization of the alphasynuclein protofibril by a dopamine-alpha-synuclein adduct. Science 294: 1346-1349. doi: 10.1126/science.1063522 PMID: 11701929
51. Mysling S, Betzer C, Jensen PH, Jorgensen TJ (2013) Characterizing the Dynamics of alpha-Synuclein Oligomers Using Hydrogen/Deuterium Exchange Monitored by Mass Spectrometry. Biochemistry 52: 9097-9103. doi: 10.1021/bi4009193 PMID: 24191706
52. Braak H, Sastre M, Del Tredici K (2007) Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson's disease. Acta Neuropathol 114: 231-241. doi: 10.1007/s00401-007-0244-3 PMID: 17576580
53. Gai WP, Pountney DL, Power JH, Li QX, Culvenor JG, et al. (2003) alpha-Synuclein fibrils constitute the central core of oligodendroglial inclusion filaments in multiple system atrophy. Exp Neurol 181: 68-78. doi: 10.1016/S0014-4886(03)00004-9 PMID: 12710935
54. Danzer KM, Haasen D, Karow AR, Moussaud S, Habeck M, et al. (2007) Different species of alphasynuclein oligomers induce calcium influx and seeding. J Neurosci 27: 9220-9232. doi: 10.1523/JNEUROSCI.2617-07.2007 PMID: 17715357
55. Paslawski W, Andreasen M, Nielsen SB, Lorenzen N, Thomsen K, et al. (2014) High Stability and Cooperative Unfolding of alpha-Synuclein Oligomers. Biochemistry 53: 6252-6263. doi: 10.1021/bi5007833 PMID: 25216651
56. Nakamura K, Nemani VM, Wallender EK, Kaehlcke K, Ott M, et al. (2008) Optical reporters for the conformation of alpha-synuclein reveal a specific interaction with mitochondria. J Neurosci 28: 12305-12317. doi: 10.1523/JNEUROSCI.3088-08.2008 PMID: 19020024
57. Devi L, Raghavendran V, Prabhu BM, Avadhani NG, Anandatheerthavarada HK (2008) Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J Biol Chem 283: 9089-9100. doi: 10.1074/jbc.M710012200 PMID: 18245082
58. Cali T, Ottolini D, Negro A, Brini M (2012) alpha-Synuclein controls mitochondrial calcium homeostasis by enhancing endoplasmic reticulum-mitochondria interactions. J Biol Chem 287: 17914-17929. doi: 10.1074/jbc.M111.302794 PMID: 22453917
59. Sarafian TA, Ryan CM, Souda P, Masliah E, Kar UK, et al. (2013) Impairment of mitochondria in adult mouse brain overexpressing predominantly full-length, N-terminally acetylated human alpha-synuclein. PLoS One 8: e63557. doi: 10.1371/journal.pone.0063557 PMID: 23667637
60. Pennington K, Peng J, Hung CC, Banks RE, Robinson PA (2010) Differential effects of wild-type and A53T mutant isoform of alpha-synuclein on the mitochondrial proteome of differentiated SH-SY5Y cells. J Proteome Res 9: 2390-2401. doi: 10.1021/pr901102d PMID: 20334438
61. Xilouri M, Stefanis L (2011) Autophagic pathways in Parkinson disease and related disorders. Expert Rev Mol Med 13: e8. doi: 10.1017/S1462399411001803 PMID: 21418705
62. Mazzulli JR, Xu YH, Sun Y, Knight AL, McLean PJ, et al. (2011) Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell 146: 37-52. doi: 10.1016/j.cell.2011.06.001 PMID: 21700325
63. Ejlerskov P, Rasmussen I, Nielsen TT, Bergstrom AL, Tohyama Y, et al. (2013) Tubulin polymerizationpromoting protein (TPPP/p25alpha) promotes unconventional secretion of alpha-synuclein through exophagy by impairing autophagosome-lysosome fusion. J Biol Chem 288: 17313-17335. doi: 10. 1074/jbc.M112.401174 PMID: 23629650
64. Burre J, Sharma M, Sudhof TC (2012) Systematic mutagenesis of alpha-synuclein reveals distinct sequence requirements for physiological and pathological activities. J Neurosci 32: 15227-15242. doi: 10.1523/JNEUROSCI.3545-12.2012 PMID: 23100443
65. Ritz B, Rhodes SL, Qian L, Schernhammer E, Olsen JH, et al. (2010) L-type calcium channel blockers and Parkinson disease in Denmark. Ann Neurol 67: 600-606. doi: 10.1002/ana.21937 PMID: 20437557
66. Jen JC, Wan J, Palos TP, Howard BD, Baloh RW (2005) Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures. Neurology 65: 529-534. doi: 10.1212/01.wnl. 0000172638.58172.5a PMID: 16116111
67. Chartier-Harlin MC, Dachsel JC, Vilarino-Guell C, Lincoln SJ, Lepretre F, et al. (2011) Translation initiator EIF4G1 mutations in familial Parkinson disease. Am J Hum Genet 89: 398-406. doi: 10.1016/j.ajhg. 2011.08.009 PMID: 21907011
68. Nuytemans K, Bademci G, Inchausti V, Dressen A, Kinnamon DD, et al. (2013) Whole exome sequencing of rare variants in EIF4G1 and VPS35 in Parkinson disease. Neurology 80: 982-989. doi: 10.1212/WNL.0b013e31828727d4 PMID: 23408866
69. Kim SS, Moon KR, Choi HJ (2011) Interference of alpha-synuclein with cAMP/PKA-dependent CREB signaling for tyrosine hydroxylase gene expression in SK-N-BE(2)C cells. Arch Pharm Res 34: 837-845. doi: 10.1007/s12272-011-0518-0 PMID: 21656370
70. Outeiro TF, Kontopoulos E, Altmann SM, Kufareva I, Strathearn KE, et al. (2007) Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease. Science 317: 516-519. doi: 10.1126/science.1143780 PMID: 17588900
71. Liu L, Arun A, Ellis L, Peritore C, Donmez G (2012) Sirtuin 2 (SIRT2) enhances 1-methyl-4-phenyl- 1, 2, 3, 6-tetrahydropyridine (MPTP)-induced nigrostriatal damage via deacetylating forkhead box O3a (Foxo3a) and activating Bim protein. J Biol Chem 287: 32307-32311. doi: 10.1074/jbc.C112.403048 PMID: 22898818
72. Jensen PH, Islam K, Kenney J, Nielsen MS, Power J, et al. (2000) Microtubule-associated protein 1B is a component of cortical Lewy bodies and binds alpha-synuclein filaments. J Biol Chem 275: 21500-21507. doi: 10.1074/jbc.M000099200 PMID: 10764738
73. Alim MA, Ma QL, Takeda K, Aizawa T, Matsubara M, et al. (2004) Demonstration of a role for alphasynuclein as a functional microtubule-associated protein. J Alzheimers Dis 6: 435-442; discussion 443-439. PMID: 15345814